EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Natural compounds in the management of polycystic ovary syndrome: a comprehensive review of hormonal regulation and therapeutic potential

Jingyi Yuan, Zhenmin Li, Yongjiang Yu, Xiuge Wang, Yunyun Zhao

Frontiers in Nutrition · 11.02.2025 · 12

DOI: 10.3389/fnut.2025.1520695 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Frontiers in Nutrition, online erschienen am 11.02.2025. Verfasst von Jingyi Yuan und 4 weiteren Autor:innen. Beteiligte Einrichtung: College of Chinese Medicine, Changchun University of Chinese Medicine, Changchun, Jilin, China. Die Arbeit wurde bisher 42-mal zitiert (Crossref) und nennt 150 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Polycystic ovary syndrome (PCOS) is a multifaceted endocrine disorder characterized by irregularities in gonadotropin secretion, hyperandrogenism, chronic anovulation, and polycystic ovarian morphology. In addition, it is often associated with metabolic dysfunctions, most notably insulin resistance (IR). This disorder affects approximately 6–20% of individuals, primarily emerging during early adolescence, and considerably increases the risk of conditions such as impaired glucose tolerance, type 2 diabetes, endometrial cancer, cardiovascular diseases, dyslipidemia, and postpartum complications. To date, there is no standardized protocol for treating PCOS. Existing therapies primarily rely on personalized pharmacotherapy and lifestyle modifications. However, these treatments may often lead to adverse effects, and most medications prescribed for PCOS are used off-label and have not secured approval from the U.S. Food and Drug Administration specifically for this condition. Recently, natural compounds have garnered considerable attention due to their efficacy in hormone modulation and minimal toxicity. Substances such as myo-inositol, resveratrol, berberine, and quercetin have shown promise in mitigating PCOS symptoms. Their multi-target properties offer the potential to achieve outcomes unattainable by single-target pharmaceuticals, particularly in managing heterogeneous conditions. This review aims to comprehensively analyze in vivo and in vitro research alongside clinical interventions to evaluate the influence of natural compounds on the prevalence of PCOS and their therapeutic potential. These investigations lay the groundwork for developing innovative therapeutic strategies for PCOS.

Schlagwörter

Stichwörter der Autor:innen

hormone regulationinsulin resistancenatural compoundspolycystic ovary syndrometherapeutic strategies

Autor:innen und Institutionen

  • College of Chinese Medicine, Changchun University of Chinese Medicine, Changchun, Jilin, China.
  • Department of Endocrine and Metabolic Disease, The Affiliated Hospital to Changchun University of Chinese Medicine, Changchun, Jilin, China.

Zitieren

APA

Yuan, J., Li, Z., Yu, Y., Wang, X., & Zhao, Y. (2025). Natural compounds in the management of polycystic ovary syndrome: a comprehensive review of hormonal regulation and therapeutic potential. Frontiers in Nutrition, 12. https://doi.org/10.3389/fnut.2025.1520695

Vancouver

Yuan J, Li Z, Yu Y, Wang X, Zhao Y. Natural compounds in the management of polycystic ovary syndrome: a comprehensive review of hormonal regulation and therapeutic potential. Frontiers in Nutrition. 2025;12. doi:10.3389/fnut.2025.1520695

BibTeX
@article{Yuan2025,
  author = {Yuan, Jingyi and Li, Zhenmin and Yu, Yongjiang and Wang, Xiuge and Zhao, Yunyun},
  title = {Natural compounds in the management of polycystic ovary syndrome: a comprehensive review of hormonal regulation and therapeutic potential},
  journal = {Frontiers in Nutrition},
  year = {2025},
  volume = {12},
  doi = {10.3389/fnut.2025.1520695}
}
Kostenlos starten →